Fig. 6: Functional precision oncology-guided treatment for FMOC02 in the clinic.

Schematic representation of FMOC02 patient’s CA125 levels, measured during different treatments guided by the functional precision oncology approach. The dots indicate CA125 measurement timepoints, black arrows mark the start of a new clinical treatment, minor ticks on the x-axis refer to the months and major ticks to the years. Bottom: representative CT scans, linked with the time-point of the treatment. Red arrows point toward the tumour in the CT scan.